Physician

Bela Ajtai, MD, PHD

According to 2025 Medicare claims, Bela Ajtai, MD, PHD (NPI: 1316155500) practices neurology in the Buffalo-Cheektowaga, NY market, with the plurality of this provider's patient population coming from Erie, NY. This provider's primary affiliated billing organization is DENT NEUROLOGIC GROUP LLP (NPI: 1497850911; TIN: 161582336) and primary practice location at 14226-1727.

Ajtai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,229 traditional Medicare patients, billed 423,172 HCPCS/CPT codes, and received $8,697,921 in Medicare payments. The top billing code was 70551 (Mri scan of brain without contrast). Part D data shows 5,439 prescription claims across 1,324 beneficiaries totaling $366,088 in drug costs, led by Gamunex-C (Immune Globul G/Gly/Iga Avg 46). 2023 DME data shows 28 claims. Open Payments data shows 172 records totaling $223,310. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $225,312 to $8,697,921. In contrast, Part D prescription costs have fallen sharply in recent years, from $1,005,256 to $366,088. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $4,150 and ending at $1,547.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,069	6,357	$225,312
2016	1,123	26,797	$740,230
2017	1,272	127,076	$3,308,887
2018	1,309	125,396	$3,342,729
2019	1,395	172,669	$3,709,655
2020	1,415	207,510	$6,485,278
2021	1,470	261,062	$6,384,494
2022	1,331	272,852	$6,715,806
2023	1,276	296,645	$6,930,660
2024	1,229	423,172	$8,697,921

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	819	5,589	$1,005,256
2016	869	5,314	$811,675
2017	957	6,669	$812,363
2018	1,063	7,264	$681,118
2019	1,165	7,126	$732,567
2020	1,326	8,176	$722,186
2021	1,254	6,334	$365,740
2022	922	3,919	$202,837
2023	1,217	4,314	$242,893
2024	1,324	5,439	$366,088

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	122	$2,639
2016	N/R	57	$1,187
2017	N/R	21	$408
2018	27	141	$3,949
2019	164	352	$11,786
2020	39	202	$6,198
2021	45	240	$9,104
2022	N/R	48	$1,385
2023	N/R	28	$612
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
70551	Mri scan of brain without contrast	210	213	$138
96413	Administration of chemotherapy into vein, 1 hour or less	168	879	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	182	198	$72
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	233	245	$11
J7050	Infusion, normal saline solution, 250 cc	243	1,314	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	12	336	$65,688
Galantamine Er	Galantamine Hbr	558	31,186	$51,114
Memantine Hcl	Memantine Hcl	1,083	62,966	$32,275
Rexulti	Brexpiprazole	15	570	$26,098
Memantine Hcl Er	Memantine Hcl	367	18,686	$25,801

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	165	$99,111	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	7	$124,199	Biogen, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bela Ajtai, MD, PHD?

Tedicare shows public-source Medicare data for Bela Ajtai, MD, PHD (NPI 1316155500), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bela Ajtai, MD, PHD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bela Ajtai, MD, PHD?

Bela Ajtai, MD, PHD is linked to DENT NEUROLOGIC GROUP LLP (billing NPI 1497850911) in the available physician profile data.

Does Bela Ajtai, MD, PHD have Open Payments data?

Bela Ajtai, MD, PHD has 172 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.